- £334.22m
- £2.25bn
- $1.63bn
- 44
- 99
- 26
- 58
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,725 | 1,396 | 1,285 | 1,783 | 1,634 |
Cost of Revenue | |||||
Gross Profit | 759 | 403 | 647 | 1,086 | 765 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,110 | 2,414 | 759 | 1,049 | 1,252 |
Operating Profit | -1,385 | -1,018 | 527 | 734 | 382 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,653 | -1,273 | 215 | 442 | 95.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,694 | -1,222 | -80.7 | 49.1 | -110 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,694 | -1,222 | -80.7 | 49.1 | -110 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,694 | -1,222 | -80.7 | 49.1 | -110 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.266 | -0.263 | -0.031 | 0.165 | 0.081 |
Dividends per Share |